Government Issues Mystery Decision About Nurse Practitioner
Published Date: 1/17/2025
Notice
Summary
Laura M. Bellew, a nurse practitioner from New Mexico, lost her DEA registration because she no longer has state permission to handle controlled substances. She didn’t ask for a hearing to challenge this, so the DEA officially revoked her registration, which expired in July 2024. This means she can’t legally prescribe or handle controlled drugs anymore.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
DEA Registration Revoked for Named Practitioner
The DEA revoked Laura M. Bellew's Certificate of Registration No. MB1966108, effective February 18, 2025. Her DEA registration had expired on July 31, 2024, and under this Order she may not legally prescribe or handle controlled substances.
Pending Renewal and New Registrations Denied
The Order also denies any pending applications by Laura M. Bellew to renew or modify her registration and denies any pending application for additional registration in New Mexico. That denial is issued pursuant to the same Order effective February 18, 2025.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-20710, Self-Regulatory Organizations; Investors Exchange LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change Pursuant to IEX Rule 15.110(a) and (c) To Modify the Required Criteria To Qualify for the Reduced Incremental Fee
Investors Exchange (IEX) is changing the rules for who can get a discount on certain trading fees. Starting November 1, 2026, members will need to meet new criteria to qualify for the reduced incremental fee, which could save or cost them money depending on their trading activity. This change affects all IEX members and kicks in right away to keep things fair and clear.
2026-20729, Proposed Agency Information Collection Activities; Comment Request
The National Credit Union Administration (NCUA) wants to update its Call Report form to include questions about credit unions’ activities with payment stablecoins. This change affects all credit unions and will start with reports due March 31, 2027. The NCUA is asking for public comments by December 8, 2026, to make sure the new form works well without causing extra costs or hassle.
2026-20702, Notice of Public Meetings of the Virginia Advisory Committee to the U.S. Commission on Civil Rights
The Virginia Advisory Committee to the U.S. Commission on Civil Rights is holding virtual public meetings to discuss how Virginia public universities are following rules about fair student admissions. Anyone interested can join these Zoom meetings on October 27, November 10, and December 15, 2026, to listen and share their thoughts. These meetings don’t cost money to attend, but phone users might pay regular call fees.
2026-20708, Self-Regulatory Organizations; Investors Exchange LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change Pursuant to IEX Rule 15.110(a) and (c) To Amend the IEX Equities Fee Schedule
IEX is shaking up its fee schedule starting November 1, 2026, by tweaking who gets rebates for adding displayed liquidity and changing rebate amounts. This affects IEX members who trade stocks, giving them new ways to save or earn more on fees. The changes kick in right away after filing, so traders should get ready to adjust their strategies and cash flow.
2026-20730, Elite Laboratories, Inc. et al.; Withdrawal of Approval of 16 Abbreviated New Drug Applications; Correction
The FDA fixed a previous announcement about pulling approval for 16 generic drug applications. Three drugs from Navinta LLC—ribavirin solution, fosaprepitant powder, and nicardipine capsules—won't lose approval because Navinta asked to keep them active. This means those three drugs stay on the market, while the other 13 still had their approvals withdrawn as planned back in July 2026.
2026-20779, Passenger Vehicle and Light Truck Tires From Thailand: Preliminary Results and Rescission, in Part, of Antidumping Duty Administrative Review; 2024-2025
The U.S. Department of Commerce found that tires from Thailand were sold in the U.S. for less than their normal price between July 2024 and June 2025. This means some importers might have to pay extra duties to keep things fair. The review process had some delays due to government shutdowns, but now the preliminary results are out and open for comments.
Previous / Next Documents
Previous: 2025-01109, Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Toxic Substances Control Act (TSCA) Existing Chemical Risk Evaluation and Management; Generic Information Collection Request for Interview and Focus Groups
The EPA is asking to keep collecting info through interviews and focus groups about chemical safety under the Toxic Substances Control Act. This affects businesses and people involved with existing chemicals, helping the EPA manage risks better. Comments on this plan are open until February 18, 2025, with no new costs expected for participants.
Next: 2025-01112, Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Threshold Setting Data Needs for the Label Program for Low Embodied Carbon Construction Materials (New)
The EPA is asking for approval to collect new info about low-carbon building materials to help create a label program. Builders, manufacturers, and environmental groups will be involved, and the EPA wants your feedback by February 18, 2025. This effort aims to boost greener construction without adding big costs or delays.